Subcutaneous sarilumab for the treatment of hospitalized patients with moderate to severe COVID19 disease: A pragmatic, embedded randomized clinical trial. uri icon

authors

  • Branch-Elliman, Westyn
  • Shah, Nishant R
  • Taylor, Thomas H
  • Page, Sarah T
  • Schiller, Sara J
  • Shannon, Colleen
  • Hau, Cynthia
  • Flynn, Maura
  • Holmberg, Erika
  • Visnaw, Karen
  • Dhond, Rupali
  • Ferguson, Ryan
  • Brophy, Mary
  • Monach, Paul A
  • Doros, Gheorghe
  • Woods, Patricia
  • Leatherman, Sarah
  • Strymish, Judith
  • Rupak Datta, MD PhD
  • Goswami, Rekha
  • Jankowich, Matthew D

publication date

  • January 1, 2022